$70.57
0.20[0.28%]
At close: Apr 26
$70.57
0[0.00%]
After Hours: 4:00PM EDT
Ligand Pharmaceuticals
(NASDAQ:LGND)Ligand Pharmaceuticals Stock (NASDAQ:LGND), Insider Trading Activity
Ligand Pharmaceuticals: Insider buying and selling updated today.
Shares Outstanding
17.958M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 07, 2024 | Stephen L Sabba | DIRECTOR | 1K | $74.30 | -$140.65K | SELL-OPTIONS | 3.58% | 28.926K | Mar 05 | View |
| Feb 29, 2024 | Octavio Espinoza | CHIEF FINANCIAL OFFICER | 8.332K | $72.54 | $59.18K | SELL-OPTIONS | 38.89% | 29.755K | Feb 27 - Feb 28 | View |
| Sep 25, 2023 | Todd C Davis | CHIEF EXECUTIVE OFFICER | 4K | $59.38 | $237.53K | BUY | 5.79% | 73.09K | Sep 22 | View |
| May 18, 2023 | John W Kozarich | DIRECTOR | -4.444K | $77.20 | -$343.08K | SELL | -10.35% | 38.488K | May 16 | View |
| May 12, 2023 | Stephen L Sabba | DIRECTOR | 0 | $77.13 | -$494.22K | SELL-OPTIONS | 0.00% | 25.784K | May 10 | View |
| May 10, 2023 | John W Kozarich | DIRECTOR | 0 | $47.69 | -$370.03K | SELL-OPTIONS | 0.00% | 42.213K | May 08 | View |
| Mar 28, 2023 | Andrew Reardon | SEE REMARKS | -300 | $69.92 | -$20.98K | SELL | -1.81% | 16.308K | Mar 24 | View |
| Dec 20, 2022 | John L Higgins | DIRECTOR | -10K | $61.87 | -$618.66K | SELL | -2.31% | 422.984K | Dec 16 | View |
| Nov 21, 2022 | John L Higgins | CHIEF EXECUTIVE OFFICER | 0 | $45.55 | -$655.37K | SELL-OPTIONS | 0.00% | 426.731K | Nov 17 - Nov 18 | View |
| Nov 10, 2022 | Octavio Espinoza | CHIEF FINANCIAL OFFICER | -1.696K | $75.64 | -$128.28K | SELL | -16.07% | 8.857K | Nov 09 | View |
| Sep 16, 2022 | John L Higgins | CHIEF EXECUTIVE OFFICER | -5K | $89.61 | -$448.05K | SELL | -1.35% | 364.18K | Sep 15 - Sep 16 | View |
| May 13, 2022 | Matthew W Foehr | PRESIDENT AND COO | 2.5K | $82.76 | $206.91K | BUY | 1.46% | 173.354K | May 13 | View |
| Mar 01, 2022 | John W Kozarich | DIRECTOR | 6.427K | $57.58 | -$1.27K | SELL-OPTIONS | 18.48% | 41.209K | Feb 28 | View |
| Nov 17, 2021 | John L LaMattina | DIRECTOR | 0 | $97.08 | -$626.41K | SELL-OPTIONS | 0.00% | 25.398K | Nov 16 | View |
| Nov 12, 2021 | John L Higgins | CHIEF EXECUTIVE OFFICER | -3K | $160.50 | -$481.50K | SELL | -0.89% | 335.095K | Nov 12 | View |
| Nov 12, 2021 | Matthew W Foehr | PRESIDENT AND COO | 1.028K | $95.78 | -$1.47M | SELL-OPTIONS | 0.62% | 166.525K | Nov 11 | View |
| Aug 05, 2021 | Matthew W Foehr | PRESIDENT AND COO | 1.142K | $69.45 | -$677.76K | SELL-OPTIONS | 0.69% | 165.497K | Aug 04 | View |
| Feb 12, 2021 | Todd C Davis | DIRECTOR | -2.609K | $204.53 | -$598.73K | SELL | -4.94% | 50.152K | Feb 10 - Feb 11 | View |
| Feb 11, 2021 | Stephen L Sabba | DIRECTOR | 0 | $109.93 | -$2.89M | SELL-OPTIONS | 0.00% | 24.431K | Feb 09 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.